Borrek 1997.
| Study characteristics | ||
| Methods | Design: randomised by draw, double‐blind, placebo‐controlled, cross‐over Duration: 20 to 24 weeks Interval of assessment: 4 to 3 weeks |
|
| Participants | Number randomised: 24 children and teenagers from 3 to 17 years of age Sex (M/F): 14/10 total Age of participants: 3 to 17 years (mean age = 10 years) Unit of allocation: single person Country and setting: Germany, 1 university pediatric clinic Inclusion criteria of the study
Exclusion criteria of the study
|
|
| Interventions |
|
|
| Outcomes |
|
|
| Notes | Concommitant treatment: permitted Assessment of compliance: unsure |
|
| Risk of bias | ||
| Bias | Authors' judgement | Support for judgement |
| Random sequence generation (selection bias) | Low risk | Randomisation was by draw (entrance to study) |
| Allocation concealment (selection bias) | Unclear risk | The trial did not specify this |
| Incomplete outcome data (attrition bias) All outcomes | Low risk | 2 participants from each group withdrew due to non‐compliance |
| Selective reporting (reporting bias) | Low risk | The trial reported all prespecified outcomes |
| Other bias | Low risk | Quote (page 101): "No difference between the two groups in the most important variables" |
| Blinding of participants and personnel (performance bias) All outcomes | Low risk | Quote (page 101): "Patient and examiner were blinded with respect to after completion of the capsule contents" Comment: This was adequate (both blinded) |